April 11, 2013 (Hackensack, NJ) – John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will be hosting a Women's Oncology Conference for gynecologists and generalists on Wednesday, April 24 from 7:30am to 1:00 pm. The event is intended for general oncologists, internists and family practitioners, medical oncologists, and allied health care providers in the northern New Jersey area. The program will feature leading experts from John Theurer Cancer Center, as well as the former president of the Society of Gynecologic Oncologists, Dr. John Curtin.
"It is imperative that gynecologists and generalists are aware of frequently encountered issues in gynecologic oncology, as well as the best practices to respond to these issues," said Babak Litkhoui, M.D., co-chief of gynecologic oncology, John Theurer Cancer Center and member of Regional Cancer Care Associates. "By the end of this conference, attendees will be knowledgeable on some of the most important recent developments in gynecologic oncology."
Evolving diagnostic, screening, medical, and surgical advances continue to expand our understanding, evaluation, and management of gynecologic cancers. Most pre-malignant and malignant conditions are diagnosed primarily by general gynecologists and are, at times managed primarily by them. This program is intended to provide a gynecologic oncologists' perspective on conditions commonly encountered by the generalist. Strategies to maximize clinical outcomes, cost and patient interventions, as well as guidelines for referral for subspecialist care will be reviewed.
The conference program will include presentations from the following physicians:
"At John Theurer Cancer Center, we take seriously our commitment to continuing medical education," said Andrew Pecora, M.D., F.A.C.P., C.P.E. chief innovations officer, professor, and vice president of Cancer Services, John Theurer Cancer Center and president of Regional Cancer Care Associates. "Medical sciences and technologies are continually evolving and improving, so it is critically important that medical practitioners stay abreast of the most recent developments and discoveries in order to ensure optimal patient care."
Hackensack University Medical center is accredited by the Medical Society of New Jersey to provide Continuing Medical Education for physicians. Hackensack University Medical center designates this educational activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This event is complimentary, but registration is required. To RSVP, please contact Bonnie LoGuidice at email@example.com or 551-996-4891. For more information, visit jtcancercenter.org/events.
About John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is among the nation's top 50 U.S. News and World Report Best Hospitals for cancer – the highest-ranked in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.
Each year, more people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise—all under one roof. Physicians at John Theurer Cancer Center are members of Regional Cancer Care Associates one of the nation's largest professional hematology/oncology groups. For more information please visit jtcancercenter.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.